EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China

Weijian Huang, Shengjie Wu, Jiangang Zou, Guosheng Fu, Lan Su, Binni Cai, Min Gu, Wenxuan Shang, Xia Sheng, Xiaofeng Hou, Hongxia Niu, Xiaohong Zhou und 2 weitere

JACC: Clinical Electrophysiology · 2026-06 · 12 (6) · 1375-1389

DOI: 10.1016/j.jacep.2026.01.037 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2026-06. Verfasst von Weijian Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: weijianhuang69@126.com. Hauptthemen laut MEDLINE: Bundle of His, Cardiac Pacing, Artificial, Purkinje Fibers. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Conduction system pacing (CSP), including His bundle pacing (HBP) and left bundle branch area pacing (LBBAP), offers a physiological alternative to conventional pacing. However, current evidence is limited by small sample sizes, short follow-up, and inconsistent LBBAP definitions. OBJECTIVE: This study evaluated the long-term outcomes, safety, and lead performance of CSP in a large multicenter cohort, and provided a precise LBBAP classification for investigating its impact on clinical outcomes. METHODS: This prospective registry-based study included patients receiving CSP at 5 Chinese centers from 2019 to 2021. LBBAP was classified as left bundle branch pacing (LBBP), left ventricular septal pacing (LVSP), or unclassified LBBAP based on the presence, absence, or uncertainty of left bundle branch capture. Pacing and clinical outcomes were analyzed. RESULTS: Of 3,336 enrolled patients, 3,167 successfully received CSP (557 HBP, 2,610 LBBAP), with a mean follow-up of 41.3 ± 14.0 months. LBBAP comprised LBBP (84.2%), unclassified (12.5%), and LVSP (3.3%). In patients with LBBB and heart failure with reduced ejection fraction, LBBP and HBP achieved the greatest LVEF improvements (+20.7% and +21.9%), while LVSP showed the least (+12.1%). LVSP was associated with higher mortality or heart failure hospitalization (33.3%) compared with LBBP (8.6%) and unclassified LBBAP (15.4%). Threshold increases ≥1 V/0.5 ms occurred in 5.03% HBP vs 1.80% LBBAP (P < 0.001). Procedural complications (excluding threshold rise) occurred in 1.3% of both groups. CONCLUSIONS: CSP demonstrated long-term safety and stability. Subclassification of LBBAP enhances clinical precision, with LBBP capture yielding a higher positive clinical outcomes and LVSP with inferior outcomes, especially in cardiac resynchronization therapy patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bundle of HisCardiac Pacing, ArtificialPurkinje FibersAgedFemaleHumansMaleMiddle AgedBundle-Branch BlockChinaProspective StudiesRegistriesTreatment Outcome

Stichwörter der Autor:innen

His bundle pacingconduction system pacingleft bundle branch area pacingleft bundle branch pacingleft ventricular septal pacinglong-term outcome

Autor:innen und Institutionen

  • Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: weijianhuang69@126.com.
  • Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Cardiology, Jiangsu Province Hospital, Nanjing, China.
  • Department of Cardiology, Sir Run Run Shaw Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China.
  • Department of Cardiology, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
  • State Key Laboratory of Cardiovascular Disease, Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Zitieren

APA

Huang, W., Wu, S., Zou, J., Fu, G., Su, L., Cai, B., Gu, M., Shang, W., Sheng, X., Hou, X., Niu, H., Zhou, X., Vijayaraman, P., & Hua, W. (2026). Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China. JACC: Clinical Electrophysiology, 12(6), 1375-1389. https://doi.org/10.1016/j.jacep.2026.01.037

Vancouver

Huang W, Wu S, Zou J, Fu G, Su L, Cai B, et al. Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China. JACC: Clinical Electrophysiology. 2026;12(6):1375-1389. doi:10.1016/j.jacep.2026.01.037

BibTeX
@article{Huang2026,
  author = {Huang, Weijian and Wu, Shengjie and Zou, Jiangang and Fu, Guosheng and Su, Lan and Cai, Binni and Gu, Min and Shang, Wenxuan and Sheng, Xia and Hou, Xiaofeng and Niu, Hongxia and Zhou, Xiaohong and Vijayaraman, Pugazhendhi and Hua, Wei},
  title = {Long-Term Outcomes and Safety of His-Purkinje Conduction System Pacing in China},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  volume = {12},
  number = {6},
  pages = {1375--1389},
  doi = {10.1016/j.jacep.2026.01.037}
}
Kostenlos starten →